It will be difficult to compare Moderna, Inc. and Pfizer Inc.’s coronavirus vaccines based on their Phase III study designs, some vaccines experts said.
“Both trials appeared to be well designed,” based on publicly available information, said Ira Longini, co-director of the Center for...







